FRIESS THOMAS,MOESSNER EKKEHARD,MOSER SAMUEL,UMANA PABLO
申请号：
IN7102/CHENP/2011
公开号：
IN2011CN07102A
申请日:
2011.09.30
申请国别(地区):
IN
年份:
2012
代理人:
摘要：
The present invention provides a humanized anti-EGFR IgGl antibody and irinotecan for combined use in treating cancer, with or without additional agents or treatments, such as other anti-cancer drugs or radiation therapy. The invention also encompasses a pharmaceutical composition that is comprised of a combination of a humanized anti-EGFR IgGl antibody and irinotecan in a pharmaceutically acceptable carrier.
